

Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. They are generally manufactured through a variety of processes that include chemical synthesis, fermentation processes, recombinant DNA, etc.
Microbial fermentation APIs are secondary metabolites produced by micro-organisms such as fungi and actinomycetes. The micro-organisms are capable of converting inexpensive carbon sources (starch, glucose, sucrose, etc.) and nitrogen sources (soybean flour, cotton-seed flour, peptone, etc.) into highly valuable API's or key intermediates (such as amino acids, vitamines, antibiotics) in liquid or solid media under certain growth conditions (nutrients, temperature, PH, oxygen supply).
Microorganisms that are typically used within the pharmaceutical industry include: prokaryotes such as Bacteria (e.g. Escherichia coli, Staphylococcus aureus) and Streptomycetes (e.g. Streptomyces spp, Actinomyces spp), eukaryotes such as Filamentous Fungi (e.g., Nigrospora spp, Aspergillus spp,) and Yeast (e.g. Saccharomyces cereviciae, Pichia pastoris).
The global Microbial Fermentation APIs market is projected to grow from US$ 29820 million in 2024 to US$ 32410 million by 2030, at a Compound Annual Growth Rate (CAGR) of 1.4% during the forecast period.
The major players in global Microbial Fermentation APIs market include Merck, Ajinomoto, HGPF, etc. China is the main market, and occupies about 50% of the global market. Antibiotics and Amino Acids are main types, with a share over 60%.
Report Covers:
This report presents an overview of global market for Microbial Fermentation APIs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Microbial Fermentation APIs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Microbial Fermentation APIs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Microbial Fermentation APIs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Microbial Fermentation APIs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Microbial Fermentation APIs sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
HGPF
Huaxing
North China Pharmaceutical
Topfond
DSM
Tianyao
CSPC Pharma
Northeast Pharm
Lukang Pharmaceutical
Luwei Pharmaceutical
Jiangshan (DSM)
Segment by Type
Antibiotics
Amino Acids
Vitamin
Nucleotide
Organic Acid
Alcohol
Biological Products
Hormone
Segment by Application
Hospitals
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Microbial Fermentation APIs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Microbial Fermentation APIs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microbial Fermentation APIs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Microbial Fermentation APIs Product Introduction
1.2 Market by Type
1.2.1 Global Microbial Fermentation APIs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Antibiotics
1.2.3 Amino Acids
1.2.4 Vitamin
1.2.5 Nucleotide
1.2.6 Organic Acid
1.2.7 Alcohol
1.2.8 Biological Products
1.2.9 Hormone
1.3 Market by Application
1.3.1 Global Microbial Fermentation APIs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Microbial Fermentation APIs Sales Estimates and Forecasts 2019-2030
2.2 Global Microbial Fermentation APIs Revenue by Region
2.2.1 Global Microbial Fermentation APIs Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Microbial Fermentation APIs Revenue by Region (2019-2024)
2.2.3 Global Microbial Fermentation APIs Revenue by Region (2025-2030)
2.2.4 Global Microbial Fermentation APIs Revenue Market Share by Region (2019-2030)
2.3 Global Microbial Fermentation APIs Sales Estimates and Forecasts 2019-2030
2.4 Global Microbial Fermentation APIs Sales by Region
2.4.1 Global Microbial Fermentation APIs Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Microbial Fermentation APIs Sales by Region (2019-2024)
2.4.3 Global Microbial Fermentation APIs Sales by Region (2025-2030)
2.4.4 Global Microbial Fermentation APIs Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Microbial Fermentation APIs Sales by Manufacturers
3.1.1 Global Microbial Fermentation APIs Sales by Manufacturers (2019-2024)
3.1.2 Global Microbial Fermentation APIs Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Microbial Fermentation APIs in 2023
3.2 Global Microbial Fermentation APIs Revenue by Manufacturers
3.2.1 Global Microbial Fermentation APIs Revenue by Manufacturers (2019-2024)
3.2.2 Global Microbial Fermentation APIs Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Microbial Fermentation APIs Revenue in 2023
3.3 Global Key Players of Microbial Fermentation APIs, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Microbial Fermentation APIs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Microbial Fermentation APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Microbial Fermentation APIs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Microbial Fermentation APIs, Product Offered and Application
3.8 Global Key Manufacturers of Microbial Fermentation APIs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Microbial Fermentation APIs Sales by Type
4.1.1 Global Microbial Fermentation APIs Historical Sales by Type (2019-2024)
4.1.2 Global Microbial Fermentation APIs Forecasted Sales by Type (2025-2030)
4.1.3 Global Microbial Fermentation APIs Sales Market Share by Type (2019-2030)
4.2 Global Microbial Fermentation APIs Revenue by Type
4.2.1 Global Microbial Fermentation APIs Historical Revenue by Type (2019-2024)
4.2.2 Global Microbial Fermentation APIs Forecasted Revenue by Type (2025-2030)
4.2.3 Global Microbial Fermentation APIs Revenue Market Share by Type (2019-2030)
4.3 Global Microbial Fermentation APIs Price by Type
4.3.1 Global Microbial Fermentation APIs Price by Type (2019-2024)
4.3.2 Global Microbial Fermentation APIs Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Microbial Fermentation APIs Sales by Application
5.1.1 Global Microbial Fermentation APIs Historical Sales by Application (2019-2024)
5.1.2 Global Microbial Fermentation APIs Forecasted Sales by Application (2025-2030)
5.1.3 Global Microbial Fermentation APIs Sales Market Share by Application (2019-2030)
5.2 Global Microbial Fermentation APIs Revenue by Application
5.2.1 Global Microbial Fermentation APIs Historical Revenue by Application (2019-2024)
5.2.2 Global Microbial Fermentation APIs Forecasted Revenue by Application (2025-2030)
5.2.3 Global Microbial Fermentation APIs Revenue Market Share by Application (2019-2030)
5.3 Global Microbial Fermentation APIs Price by Application
5.3.1 Global Microbial Fermentation APIs Price by Application (2019-2024)
5.3.2 Global Microbial Fermentation APIs Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Microbial Fermentation APIs Market Size by Type
6.1.1 US & Canada Microbial Fermentation APIs Sales by Type (2019-2030)
6.1.2 US & Canada Microbial Fermentation APIs Revenue by Type (2019-2030)
6.2 US & Canada Microbial Fermentation APIs Market Size by Application
6.2.1 US & Canada Microbial Fermentation APIs Sales by Application (2019-2030)
6.2.2 US & Canada Microbial Fermentation APIs Revenue by Application (2019-2030)
6.3 US & Canada Microbial Fermentation APIs Market Size by Country
6.3.1 US & Canada Microbial Fermentation APIs Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Microbial Fermentation APIs Sales by Country (2019-2030)
6.3.3 US & Canada Microbial Fermentation APIs Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Microbial Fermentation APIs Market Size by Type
7.1.1 Europe Microbial Fermentation APIs Sales by Type (2019-2030)
7.1.2 Europe Microbial Fermentation APIs Revenue by Type (2019-2030)
7.2 Europe Microbial Fermentation APIs Market Size by Application
7.2.1 Europe Microbial Fermentation APIs Sales by Application (2019-2030)
7.2.2 Europe Microbial Fermentation APIs Revenue by Application (2019-2030)
7.3 Europe Microbial Fermentation APIs Market Size by Country
7.3.1 Europe Microbial Fermentation APIs Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Microbial Fermentation APIs Sales by Country (2019-2030)
7.3.3 Europe Microbial Fermentation APIs Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Microbial Fermentation APIs Market Size
8.1.1 China Microbial Fermentation APIs Sales (2019-2030)
8.1.2 China Microbial Fermentation APIs Revenue (2019-2030)
8.2 China Microbial Fermentation APIs Market Size by Application
8.2.1 China Microbial Fermentation APIs Sales by Application (2019-2030)
8.2.2 China Microbial Fermentation APIs Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Microbial Fermentation APIs Market Size by Type
9.1.1 Asia Microbial Fermentation APIs Sales by Type (2019-2030)
9.1.2 Asia Microbial Fermentation APIs Revenue by Type (2019-2030)
9.2 Asia Microbial Fermentation APIs Market Size by Application
9.2.1 Asia Microbial Fermentation APIs Sales by Application (2019-2030)
9.2.2 Asia Microbial Fermentation APIs Revenue by Application (2019-2030)
9.3 Asia Microbial Fermentation APIs Sales by Region
9.3.1 Asia Microbial Fermentation APIs Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Microbial Fermentation APIs Revenue by Region (2019-2030)
9.3.3 Asia Microbial Fermentation APIs Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Microbial Fermentation APIs Market Size by Type
10.1.1 Middle East, Africa and Latin America Microbial Fermentation APIs Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Microbial Fermentation APIs Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Microbial Fermentation APIs Market Size by Application
10.2.1 Middle East, Africa and Latin America Microbial Fermentation APIs Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Microbial Fermentation APIs Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Microbial Fermentation APIs Sales by Country
10.3.1 Middle East, Africa and Latin America Microbial Fermentation APIs Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Microbial Fermentation APIs Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Microbial Fermentation APIs Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Microbial Fermentation APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Ajinomoto
11.2.1 Ajinomoto Company Information
11.2.2 Ajinomoto Overview
11.2.3 Ajinomoto Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Ajinomoto Microbial Fermentation APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ajinomoto Recent Developments
11.3 HGPF
11.3.1 HGPF Company Information
11.3.2 HGPF Overview
11.3.3 HGPF Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 HGPF Microbial Fermentation APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 HGPF Recent Developments
11.4 Huaxing
11.4.1 Huaxing Company Information
11.4.2 Huaxing Overview
11.4.3 Huaxing Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Huaxing Microbial Fermentation APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Huaxing Recent Developments
11.5 North China Pharmaceutical
11.5.1 North China Pharmaceutical Company Information
11.5.2 North China Pharmaceutical Overview
11.5.3 North China Pharmaceutical Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 North China Pharmaceutical Microbial Fermentation APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 North China Pharmaceutical Recent Developments
11.6 Topfond
11.6.1 Topfond Company Information
11.6.2 Topfond Overview
11.6.3 Topfond Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Topfond Microbial Fermentation APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Topfond Recent Developments
11.7 DSM
11.7.1 DSM Company Information
11.7.2 DSM Overview
11.7.3 DSM Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 DSM Microbial Fermentation APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 DSM Recent Developments
11.8 Tianyao
11.8.1 Tianyao Company Information
11.8.2 Tianyao Overview
11.8.3 Tianyao Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Tianyao Microbial Fermentation APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Tianyao Recent Developments
11.9 CSPC Pharma
11.9.1 CSPC Pharma Company Information
11.9.2 CSPC Pharma Overview
11.9.3 CSPC Pharma Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 CSPC Pharma Microbial Fermentation APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CSPC Pharma Recent Developments
11.10 Northeast Pharm
11.10.1 Northeast Pharm Company Information
11.10.2 Northeast Pharm Overview
11.10.3 Northeast Pharm Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Northeast Pharm Microbial Fermentation APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Northeast Pharm Recent Developments
11.11 Lukang Pharmaceutical
11.11.1 Lukang Pharmaceutical Company Information
11.11.2 Lukang Pharmaceutical Overview
11.11.3 Lukang Pharmaceutical Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Lukang Pharmaceutical Microbial Fermentation APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lukang Pharmaceutical Recent Developments
11.12 Luwei Pharmaceutical
11.12.1 Luwei Pharmaceutical Company Information
11.12.2 Luwei Pharmaceutical Overview
11.12.3 Luwei Pharmaceutical Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Luwei Pharmaceutical Microbial Fermentation APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Luwei Pharmaceutical Recent Developments
11.13 Jiangshan (DSM)
11.13.1 Jiangshan (DSM) Company Information
11.13.2 Jiangshan (DSM) Overview
11.13.3 Jiangshan (DSM) Microbial Fermentation APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Jiangshan (DSM) Microbial Fermentation APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jiangshan (DSM) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Microbial Fermentation APIs Industry Chain Analysis
12.2 Microbial Fermentation APIs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Microbial Fermentation APIs Production Mode & Process
12.4 Microbial Fermentation APIs Sales and Marketing
12.4.1 Microbial Fermentation APIs Sales Channels
12.4.2 Microbial Fermentation APIs Distributors
12.5 Microbial Fermentation APIs Customers
13 Market Dynamics
13.1 Microbial Fermentation APIs Industry Trends
13.2 Microbial Fermentation APIs Market Drivers
13.3 Microbial Fermentation APIs Market Challenges
13.4 Microbial Fermentation APIs Market Restraints
14 Key Findings in The Global Microbial Fermentation APIs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Merck
Ajinomoto
HGPF
Huaxing
North China Pharmaceutical
Topfond
DSM
Tianyao
CSPC Pharma
Northeast Pharm
Lukang Pharmaceutical
Luwei Pharmaceutical
Jiangshan (DSM)
Ìý
Ìý
*If Applicable.